Closed · W81XWH-17-PRCRP-CDA · CFDA 12.420 · Discretionary
DoD Peer Reviewed Cancer, Career Development Award
Federal grant opportunity posted by Defense Health Agency Contracting Activity - DHACA, cataloged on Grants.gov.
- Varies
- Award range
- Closed
- Status
- October 4, 2017
- Close date
- 23
- Expected awards
The verdict
DoD Peer Reviewed Cancer, Career Development Award is a closed discretionary listing from Defense Health Agency Contracting Activity - DHACA that offered Varies by applicant across 23 expected awards. Future funding cycles may be published under the same CFDA number. PlainGrants indexes 1,795 other opportunities from Defense Health Agency Contracting Activity - DHACA.
- Varies
- award range
- Closed
- application status
- 23
- expected awards
- 12.420
- CFDA program
Archived opportunity record
DoD Peer Reviewed Cancer is closed (last close October 4, 2017). Check the agency catalog for replacement NOFOs. Defense Health Agency Contracting Activity - DHACA still indexes 1,795 other opportunities here.
According to Grants.gov (extract vintage 2026-08-10), this record reflects the officially published listing. See methodology.
Deadline tracker
Application window closed
Closed October 4, 2017
Est. Total Funding
$360,000
Expected Awards
23
Instrument
Grant
Description
The FY17 PRCRP Career Development Award supports independent, early-career investigators to conduct impactful research with the mentorship of an experienced cancer researcher (i.e., the Designated Mentor) as an opportunity to obtain the funding, guidance, and experience necessary for productive, independent careers at the forefront of cancer research. This award supports impactful research projects with an emphasis on discovery. Under this award mechanism, the early-career investigator is considered the Principal Investigator (PI), and the application should focus on the PI’s research and career development. It should be clear that the proposed research is intellectually designed by the PI and not a product of the Designated Mentor. Preliminary data are not required. However, logical reasoning and a sound scientific rationale for the proposed research must be demonstrated.Key elements of the Career Development Award mechanism are as follows:• Principal Investigator: The PI must be an independent, early-career researcher or physician-scientist within 10 years after completion of his/her terminal degree (excluding time spent in residency or on family medical leave). Time spent as a postdoctoral fellow is not excluded. The PI’s record of accomplishments and the proposed research will be evaluated regarding his/her potential for contributing to the FY17 PRCRP Topic Area(s) in Section II.A.1. Because career development is the focus of this award, the PI’s organization must demonstrate a commitment to the PI through confirmation of laboratory space and a minimum of 30% protected time for the proposed research, though more protected time is highly desirable.• Career Development Plan: A career development plan is required and should be prepared with appropriate guidance from the Designated Mentor. The Designated Mentor must be an experienced cancer researcher as demonstrated by a strong record of funding and publications. In addition, the Designated Mentor must demonstrate a commitment to advancing the PI’s career in cancer research. The application should include a clearly articulated strategy for acquiring the necessary skills, competence, and expertise to advance an independent career at the forefront of cancer research in at least one of the FY17 PRCRP Topic Area(s) in Section II.A.1.• PRCRP Topic Areas: The proposed research must address at least one of the FY17 PRCRP Topic Areas.• Military Relevance: The proposed research must address at least one of the FY17 PRCRP Military Relevance Focus Areas in Section II.A.2. The proposed research must be relevant to active duty Service members, Veterans, and their beneficiaries. Military relevance highlights the need to address exposures, conditions, or circumstances that are unique to the military or disproportionately represented within the military beneficiary population. Studies into cancer knowledge gaps that may affect an individual’s mission readiness, patient care, and treatment options are critical. Military relevance should be articulated with respect to the overall Military Health System, the VA, and the mission of the DHP. For more information, review the following websites: Military Health System (http://www.health.mil), VA (http://www.va.gov/), the PRCRP (http://cdmrp.army.mil/prcrp/default), and PRCRP Report to Congress (http://cdmrp.army.mil/prcrp/reports/reports).• Impact: The applicant must articulate the potential impact the proposed work will have on cancer research and/or patient care. Impactful research will, if successful, accelerate the movement of promising ideas in cancer research into clinical applications.The anticipated direct costs budgeted for the entire period of performance for an FY17 PRCRP Career Development Award will not exceed $360,000. Refer to Section II.D.5, Funding Restrictions, for detailed funding information.
Catch-all / unrestricted eligibility mark · W81XWH-17-PRCRP-CDA
Grants.gov marks DoD Peer Reviewed Cancer with a catch-all / unrestricted eligibility code (Unrestricted / see official listing). Read the official announcement text for the real applicant filter — the code alone is not a door list. The extract does not mark applicant cost-sharing as required. Instrument: Grant. Funding-activity code maps to Science and Technology / R&D (ST). This eligibility-code string dominates the Defense Health Agency Contracting Activity - DHACA book (1,791 peers, 100% of 1,796).
- Code 99
- Unrestricted / see official listing
Codes are Grants.gov eligibility category values from the extract vintage 2026-08-10. Confirm the full eligibility statement on the official listing or the Grants.gov eligibility reference.
Official Listing on Grants.gov
View full details, application forms, and submission instructions.
Agency Contact
CDMRP Help Desk Phone: 301-682-5507 Email: help@eBRAP.org
More from Defense Health Agency Contracting Activity - DHACA
DoW Neurofibromatosis Synergistic Idea Award
DoW Neurofibromatosis Investigator-Initiated Research Award
DoW Neurofibromatosis Research Academy – Scholar Award
DoW Neurofibromatosis Exploration-Hypothesis Development Award
DOW Combat Readiness – Medical Research Program Translational Research Award
What to do next
DoD Peer Reviewed Cancer is closed; use the parent program and agency catalog for the next funding cycle.
- Browse open federal opportunities in the same category when this listing is closed. Open opportunities
- Look up CFDA 12.420 across all indexed listings before you commit to this opportunity alone. Eligibility finder
- Compare award ranges across federal categories before you pick a single CFDA. All categories
Opportunity deadlines and eligibility change on Grants.gov; PlainGrants mirrors the extract and is not the submission system.
Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.
Read our methodology - how this data is sourced, computed, and verified.
| Publisher | PlainGrants |
| Sources | the SAM.gov Assistance Listings and Grants.gov |